Thomas Meyer
Impact in
- Hematology top 1%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Organic Chemistry top 1%
- Synthesis and biological activity
Papers in
-
- Protein Kinase Regulation and GTPase Signaling 22
- Cancer therapeutics and mechanisms 6
- Angiogenesis and VEGF in Cancer 5
-
- Synthesis and biological activity 19
- Co-authors
- Doriano Fabbro (32 shared papers)Helmut Mett (15 shared papers)Elisabeth Buchdunger (12 shared papers)Nicholas Lydon (11 shared papers)J. Zimmermann (8 shared papers)Pascal Furet (21 shared papers)Paul William Manley (11 shared papers)Peter M. Traxler (11 shared papers)
- Journals
- Journal of Medicinal Chemistry (12 papers)Bioorganic & Medicinal Chemistry Letters (10 papers)Cancer Cell (3 papers)Cancer Research (3 papers)Recent results in cancer research (2 papers)
- Partner nations
- SwitzerlandFranceUnited States
In The Last Decade
Thomas Meyer
70 papers receiving 6.5k citations
Thomas Meyer's Hit Papers
Peers
Comparison fields: 5 of 117
- Hematology 1.2k
- Organic Chemistry 1.2k
- Molecular Biology 2.3k
- Computational Theory and Mathematics 547
- Oncology 553
Countries citing papers authored by Thomas Meyer
This map shows the geographic impact of Thomas Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Meyer more than expected).
Fields of papers citing papers by Thomas Meyer
This network shows the impact of papers produced by Thomas Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Meyer. The network helps show where Thomas Meyer may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Meyer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative. Hit paper breakdown → | 1996 | 920 |
| 2 | 2002 | 521 | |
| 3 | 2004 | 475 | |
| 4 | 2004 | 284 | |
| 5 | 2005 | 282 | |
| 6 | 2002 | 274 | |
| 7 | 1995 | 256 | |
| 8 | 2002 | 220 | |
| 9 | 1997 | 211 | |
| 10 | 1997 | 194 | |
| 11 | 2007 | 190 | |
| 12 | 2003 | 187 | |
| 13 | 2004 | 152 | |
| 14 | 1996 | 141 | |
| 15 | 1996 | 129 | |
| 16 | 1999 | 127 | |
| 17 | 1996 | 125 | |
| 18 | 2003 | 122 | |
| 19 | 2000 | 110 | |
| 20 | 1997 | 106 |
About Thomas Meyer
Thomas Meyer is a scholar working on Molecular Biology, Organic Chemistry, Hematology, Pathology and Forensic Medicine and Oncology, having authored 70 papers that have together received 6.9k indexed citations. Recurring topics across this work include Protein Kinase Regulation and GTPase Signaling (22 papers), Synthesis and biological activity (19 papers), Chronic Myeloid Leukemia Treatments (8 papers), Cancer therapeutics and mechanisms (6 papers), Computational Drug Discovery Methods (6 papers), Cancer Mechanisms and Therapy (6 papers), Angiogenesis and VEGF in Cancer (5 papers) and HER2/EGFR in Cancer Research (5 papers). The work is most often cited by research in Hematology (1.2k citations), Organic Chemistry (1.2k citations), Molecular Biology (2.3k citations), Computational Theory and Mathematics (547 citations) and Oncology (553 citations). Thomas Meyer has collaborated with scholars based in Switzerland, France and United States. Frequent co-authors include Doriano Fabbro, Helmut Mett, Elisabeth Buchdunger, Nicholas Lydon, J. Zimmermann, Pascal Furet, Paul William Manley, Peter M. Traxler, Sandra W. Cowan‐Jacob and Janis Liebetanz. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Cancer Cell, Cancer Research and Recent results in cancer research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.